| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| 10/22/2026 | ±1.8% | +1.7% | over-priced |
| 07/23/2026 | ±2.7% | +5.7% | under-priced |
| 04/23/2026 | ±2.9% | -2.6% | over-priced |
| 02/17/2026 | ±2.2% | +0.5% | over-priced |
| 10/23/2025 | ±1.7% | +6.8% | under-priced |
| 07/24/2025 | ±1.4% | -6.2% | under-priced |
| 04/29/2025 | ±2.2% | +5.4% | under-priced |
| 02/14/2025 | ±2.0% | -1.2% | over-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q3 FY2026 | $2.08 | $5.0B | $664M |
| Q2 FY2026 | $17.83 | $9.7B | $5.7B |
| Q1 FY2026 | $1.29 | $9.1B | $821M |
| Q4 FY2025 | $-0.18 | $9.8B | $-115M |
HON (HON) reports in 86 days, with the next report estimated for 01/21/2027. Across the last 8 reports, options priced an average ±2.1% earnings move while the stock actually moved 3.8% on average — the market has been roughly fair on HON's earnings risk. Fundamentals into the print: EPS down 27.3% year-over-year, revenue down 52.0%. QuantLogix's live 5-factor engine currently reads HON as a neutral at 49/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →